CALC CalciMedica, Inc.
$1.98▼ -6.60%
Healthcare
Other
After hours
$2.02▲ +1.97%
Sep 11, 7:30 PM ET
Volume 23.0K
Avg Volume (10D) 142.8K
Key Metrics & Fundamentals
Market Cap
$13.52M
P/E Ratio
–
Div Yield
–%
52W Range
1.91 - 36.00
% vs 50 MA
-41.07%
% vs 200 MA
-76.22%
RSI-14
34.1
MACD Histogram
+0.0000
Beta (1Y vs SPY)
0.63
Free Cash Flow
-$4.62M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$3.72M
COGS
–
Operating Exp
$4.01M
Operating Income
-$4.01M
EBIT
-$4.01M
Pretax Income
-$7.65M
Net Income
-$7.65M
EPS (Diluted)
-0.45
Price & Volume History
Loading chart…
Recent News
CalciMedica to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Sep 8, 2026 11:00 AM
CalciMedica Announces One-for-Five Reverse Stock Split
GlobeNewswire · Aug 27, 2026 1:00 PM
CalciMedica stock gains 6% as pulmonary hypertension progress offsets Q2 earnings miss
InvestorsHub · Aug 11, 2026 2:11 PM
CalciMedica Reports Second Quarter 2026 Financial Results and Provides Clinical & Corporate Updates
GlobeNewswire · Aug 11, 2026 11:00 AM
CalciMedica Reaches FDA Alignment on Phase 2b Trial Design for Auxora in Acute Pancreatitis
MT Newswires · Jul 29, 2026 2:08 PM
CalciMedica Announces FDA Alignment on Phase 2b Trial Design for Auxora in Acute Pancreatitis and Identifies Disease's First Potential Registrational Endpoints
PR Newswire · Jul 29, 2026 11:00 AM
CalciMedica Says Auxora Phase 2 Trial May Continue Dosing After FDA Review
MT Newswires · Jun 24, 2026 11:47 AM
CalciMedica Announces Private Placement Financing for Up to Approximately $49 Million to Advance Pulmonary Hypertension Program
PR Newswire · Jun 24, 2026 11:01 AM
CalciMedica Announces Clinical Development of Auxora May Proceed Following FDA Review of KOURAGE Trial Interim Safety Data
PR Newswire · Jun 24, 2026 11:00 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See CALC's money flow as a full page
Social Sentiment
Avg +0.70 · 2 posts
DiscussionTradeMade a compound interest calc cause I didn't like the public ones I found.
r/investing · Apr 3, 2025
The calculator is praised as 'amazing' and the author expresses gratitude for feedback, indicating a positive sentiment towards the project.
positive
+0.70
DDDiscussionEarningsYolo calc
r/wallstreetbets · Nov 9, 2024
The post expresses optimism about the company's debt reduction, share buybacks, and dividend potential.
positive
+0.70
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.